Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib

ObjectivesTo develop and validate a deep learning-based overall survival (OS) prediction model in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) plus sorafenib.MethodsThis retrospective multicenter study consisted of 201 patients with treatment-naïve...

Full description

Bibliographic Details
Main Authors: Lei Zhang, Wei Xia, Zhi-Ping Yan, Jun-Hui Sun, Bin-Yan Zhong, Zhong-Heng Hou, Min-Jie Yang, Guan-Hui Zhou, Wan-Sheng Wang, Xing-Yu Zhao, Jun-Ming Jian, Peng Huang, Rui Zhang, Shen Zhang, Jia-Yi Zhang, Zhi Li, Xiao-Li Zhu, Xin Gao, Cai-Fang Ni
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
sorafenib
deep learning
biomarker
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.593292/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.593292/full

Similar Items